Fig. 2From: Establishment and validation of an immune infiltration predictive model for ovarian cancerEstablishment and validation of the IPM. Kaplan-Meier analysis for training cohort (A), and testing cohort GSE13876 (B), GSE30161 (C), and GSE51088 (D). Time-dependent ROC curve analysis for training cohort (E), and testing cohort GSE13876 (F), GSE30161 (G), and GSE51088 (H). Risk score assessment for training cohort (I) and testing cohort GSE13876 (J), GSE30161 (K), and GSE51088 (L)Back to article page